the melo pearl

the melo pearl

CV

Research Scientist · Aspiring Physician-Scientist · Seoul, South Korea

Profile

Medical doctor in Traditional Medicine and research scientist with an M.S. in Medicine, building a career as a physician-scientist. Hands-on expertise in regenerative medicine, focused on cell therapy, organoids and organ-on-a-chip platforms. Currently at the Asian Frontier Stem Cell Laboratory, Yonsei University, working with leading researchers on AI-NAMs and Parkinson's disease cell therapy.

Experience

Researcher & Teaching Assistant · Nov 2025 – Present

Asian Frontier Stem Cell Lab, Dept. of Physiology, Yonsei University College of Medicine

  • Researching HLA type–dependent immune rejection in Parkinson's disease cell therapy

Researcher · Dec 2024 – Jul 2025

Prof. Heo Chan-young's Lab, Seoul National University Bundang Hospital (SNUBH)

  • Contributed to a multi-omics and organoid-based potency evaluation system for gene therapy products
  • Supported an organoid-based animal-replacement resource bank; set up lab infrastructure

Researcher, Part Leader · Sep 2022 – Oct 2024

Cell R&D Team, Cellapeutics Bio, South Korea

  • Developed cell therapies via chemically induced fibroblast reprogramming; studied mode of action (IF, ELISA, qPCR)
  • Built a Multiple Cellular Senescence Scoring System to quantify aging phenotypes

Graduate Researcher · 2020 – 2022

Dept. of Precision Medicine, Sungkyunkwan University

  • Identified 5 FDA-approved compounds as novel regulators of exosome secretion by screening the Prestwick Chemical Library with NTA
  • Established 3D fibroblast spheroid cultures and optimized exosome isolation and characterization

Education

M.S., Medicine · 2020 – 2022

Sungkyunkwan University, South Korea

Medical Doctor in Traditional Medicine · 2012 – 2018

"New Medicine" University, Mongolia · GPA 3.9 / 4.0, graduated with honors

Publications

  1. Batchuluun K, Batjargal K, Tsevgee A, Enkhtur A, et al. Newborn screening and biobanking for preventable genetic disorders in Mongolia: A developing country perspective. Regenerative Therapy. 2026;33:101163.
  2. Enkhtur A, Yoon JS, Lee CW. Factors increasing the risk of mortality and morbidity due to coronavirus infection in patients with metabolic syndrome. Precision and Future Medicine. 2020;4(3):83–90.

Research keywords

Cell therapy · Stem cells · Exosomes · Organoids · Organ-on-a-chip · Synucleinopathy · Parkinson's disease · Neuroimmunology

Skills

  • Cell culture: fibroblasts (HF87, BJ), HaCaT, keratinocytes, 293T, primary neurons; 3D spheroid and organoid culture
  • Exosomes: isolation (PEG), NTA, lysis, BCA assay
  • Assays: ELISA, CCK-8, IF/ICC, IHC, β-gal, flow cytometry, wound healing
  • Molecular: RNA/cDNA, qPCR, Western blot, gel electrophoresis, transfection, cloning
  • Data and software: GraphPad Prism, ImageJ / Fiji, R (basic), AI tools for research and writing, Microsoft Office

Languages

Mongolian (native) · English (IELTS 7.0) · Korean (TOPIK Level 6)

Would you be my friend on this road?

InstagramStudy with meYouTube, coming soon